H1N1 in post-pandemic period

Director-General’s opening statement at virtual press conference 10 August 2010   H1N1 in post-pandemic period   The world is no longer in phase 6 of influenza pandemic alert. We are now moving into the post-pandemic period. The new H1N1 virus has largely run its course. These are the views of members of the Emergency Committee, which was convened earlier today by...

Read More

NIH-Funded Scientists Find 2009 H1N1 Pandemic Influenza Vaccine Protects Mice from 1918 Influenza Virus

Mice injected with a 2009 H1N1 pandemic influenza vaccine and then exposed to high levels of the virus responsible for the 1918 influenza pandemic do not get sick or die, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The new vaccine works against the old virus because the 1918 and the 2009 strains of H1N1...

Read More

Study links pandemic spread to gaps in paid sick leave

Lisa Schnirring  Staff Writer Feb 16, 2010 (CIDRAP News) – Employees without paid sick days were more likely to work when they were sick during the peak of the fall pandemic wave and may have extended the outbreak by infecting their coworkers, according to a research group. Using data from the US Centers for Disease Control and Prevention (CDC) and the US Department of Labor, the...

Read More

Statement by Dr Keiji Fukuda on behalf of WHO at the Council of Europe hearing on pandemic (H1N1) 2009

Jan. 26, 2010   WHO is pleased to take part in this hearing, and thanks the Council of Europe for taking this initiative. The H1N1 influenza pandemic has created immensely complicated challenges for countries as well as the global community. At the same time, rising to this challenge has created an unprecedented level of global cooperation and coordination among countries in confronting a...

Read More

Did the WHO Exaggerate the H1N1 Flu Pandemic’s Danger?

  Top of Form By EBEN HARRELL Eben Harrell – Time Magazine Tue Jan 26, 5:25 am ET By the summer of 2009, shortly after the H1N1 flu pandemic had first emerged, there was a waiting list for the first several million doses of the forthcoming new flu vaccine. At the head of the line, naturally, were the world’s richest nations. “Again we see the advantage of affluence,”...

Read More